Olga Abramova

TL;DR: N nanoparticles can substantially improve the drug delivery as its implication can increase BBB permeability, the pharmacodynamics and bioavailability of applied drugs, thereby enabling nanotechnology to overcome the limitations of existing pharmacotherapy of psychiatric disorders.

TL;DR: Evidence is presented that the OXT/AVP systems are involved in the formation of social, working, spatial and episodic memory, mediated by such brain structures as the hippocampal CA2 and CA3 regions, amygdala and prefrontal cortex.

TL;DR: This scientific review aims to summarize the current knowledge about neurobiological mechanisms of cognitive impairment in people with schizophrenia, depression, mild cognitive impairment and dementia (including Alzheimer’s disease).

TL;DR: It is shown that patients with the TT allele (BDNF rs6265) had more severe impairments in frontal lobe function and a1-PI can serve as a marker for assessing the severity of frontal lobe damage in patients with frontal dementia.

TL;DR: For successful treatment of patients with schizophrenia, the discussed factors must be considered and schizophrenia treatment methods should be primarily aimed at improving social functioning.